Psychosis is a major disabling and disruptive mental illness characterized by a wide variety of disturbances in cognition and emotions, resulting in poor psychosocial functioning and frequent relapses. Despite convincing evidence of short-term symptom control and functional recovery, there has been a limited amount of data generated over the past two decades on the long-term outcomes of early interventions for psychotic patients (especially, first-episode psychosis, FEP). We propose a controlled trial with an adequate study power to examine the longer-term effects (18 months) of a Peer-facilitated, Recovery-focused Self-Illness-Management program (Peer-RESIM) for adults with FEP. Specifically, the proposed study will assess the effects of better-prepared PSWs, and a culturally adapted intervention protocol designed by our multidisciplinary research team, on improving patients' self-care and recovery.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Questionnaire about the Process of Recovery (QPR)
Timeframe: Total score self-reported at recruitment
Questionnaire about the Process of Recovery (QPR)
Timeframe: Total score self-reported at 1 week post-intervention
Questionnaire about the Process of Recovery (QPR)
Timeframe: Total score self-reported at 9 months post-intervention
Questionnaire about the Process of Recovery (QPR)
Timeframe: Total score self-reported at 18 months post-intervention
Specific Level of Functioning Scale (SLOF)
Timeframe: Total score self-reported at recruitment
Specific Level of Functioning Scale (SLOF)
Timeframe: Total score self-reported at 1 week post-intervention
Specific Level of Functioning Scale (SLOF)
Timeframe: Total score self-reported at 9 months post-intervention
Specific Level of Functioning Scale (SLOF)
Timeframe: Total score self-reported at 18 months post-intervention